header image

Research Partnerships

Our research partnerships are founded on a mutual agreement that research and discovery should be data driven with appropriate operational checks and balances. Cephalon clinical achievements are tangible proof of our commitment to collaborative innovation. But just as important are the contributions these partnerships have brought to the advancement of science.

Cephalon is a good place to bring ideas. We support Research in three ways:

  • Preclinical Studies: If you are interested in submitting a preclinical ISS proposal, please submit an online proposal.
  • Cephalon Sponsored Studies: If you would like to be involved as an Investigator with a Cephalon clinical study, please fill out our online form.
  • Investigator Sponsored Studies (ISS): In an ISS, the Investigator assumes responsibility for all aspects of the investigation, including:
    • Trial design
    • Ensuring appropriate institutional and regulatory approval
    • Study conduct, including responsibility for ensuring appropriate medical safeguards, medical monitoring, and medical supervision
    • Analysis and interpretation of the results
    • Communication of the results (e.g., publications)
    If you would like to request support for an ISS, please select one of the following links. Following our initial review, if we’re interested in learning more about your study concept, we will ask you to submit a full study protocol and budget for further evaluation to make a final determination on your proposal. You may also submit a copy of a full study protocol and budget, if available, for our initial review, but this is not required.

Submit a new proposal or access a proposal submitted for CNS or Oncology »

Biologics

Cephalon has a recommitment to the development of biologics. Our commitment to this area allows to expand our reach by approaching disease in a different way. If you have an interest in partnering with the Cephalon biologics division on a research program, please send a message to biologics@cephalon.com.